Literature DB >> 10679911

Identification of breakpoint cluster regions at 1p36.3 and 3q21 in hematologic malignancies with t(1;3)(p36;q21).

S Shimizu1, K Suzukawa, T Kodera, T Nagasawa, T Abe, M Taniwaki, F Yagasaki, H Tanaka, S Fujisawa, B Johansson, T Ahlgren, J Yokota, K Morishita.   

Abstract

The reciprocal translocation t(1;3)(p36;q21) is associated with myelodysplastic syndromes (MDSs) and acute myeloid leukemia (AML) characterized by trilineage dysplasia, in particular dysmegakaryocytopoiesis, and a poor prognosis. As yet no molecular genetic analyses of the t(1;3) have been reported. In four patients with t(1;3), all of whom had AML-M4, which evolved from MDS, the breakpoints at 3q21 clustered within a 60-kb region centromeric to the breakpoint of the inv(3)(q21q26), whereas the breakpoints at 1p36 clustered within a 90-kb region at 1p36.3. The presence of novel clusters in both the 3q21 and 1p36 breakpoints (BCRs) suggests a common, underlying molecular mechanism for the development of t(1;3)-positive MDS/AML. The Ribophorin I (RPN1) gene close to the BCR at 3q21 was highly expressed without gross structural changes, whereas the GR6 gene located within the BCR at 3q21 was not expressed. No other highly expressed genes were isolated in a 150-kb region at 3q21. Thus, it is likely that a gene at 1p36.3 is activated by the translocation of the 3q21 region or a gene important for transformation lies on 3q21, outside the 150-kb region. Further characterization of the BCRs at 1p36.3 and 3q21 should provide important insights into the molecular genetic mechanisms involved in the genesis of t(1;3)-positive MDS/AML. Genes Chromosomes Cancer 27:229-238, 2000. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10679911     DOI: 10.1002/(sici)1098-2264(200003)27:3<229::aid-gcc2>3.0.co;2-0

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  9 in total

1.  An efficient and robust statistical modeling approach to discover differentially expressed genes using genomic expression profiles.

Authors:  J G Thomas; J M Olson; S J Tapscott; L P Zhao
Journal:  Genome Res       Date:  2001-07       Impact factor: 9.043

2.  PRDM16 Suppresses MLL1r Leukemia via Intrinsic Histone Methyltransferase Activity.

Authors:  Bo Zhou; Jingya Wang; Shirley Y Lee; Jie Xiong; Natarajan Bhanu; Qi Guo; Peilin Ma; Yuqing Sun; Rajesh C Rao; Benjamin A Garcia; Jay L Hess; Yali Dou
Journal:  Mol Cell       Date:  2016-04-14       Impact factor: 17.970

3.  PRDM16s transforms megakaryocyte-erythroid progenitors into myeloid leukemia-initiating cells.

Authors:  Tianyuan Hu; Kiyomi Morita; Matthew C Hill; Yajian Jiang; Ayumi Kitano; Yusuke Saito; Feng Wang; Xizeng Mao; Kevin A Hoegenauer; Kazuhiro Morishita; James F Martin; P Andrew Futreal; Koichi Takahashi; Daisuke Nakada
Journal:  Blood       Date:  2019-07-03       Impact factor: 22.113

Review 4.  Leukemogenesis of the EVI1/MEL1 gene family.

Authors:  Kazuhiro Morishita
Journal:  Int J Hematol       Date:  2007-05       Impact factor: 2.490

5.  Overexpression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in mice.

Authors:  Danielle C Shing; Maurizio Trubia; Francesco Marchesi; Enrico Radaelli; Elena Belloni; Cinzia Tapinassi; Eugenio Scanziani; Cristina Mecucci; Barbara Crescenzi; Idoya Lahortiga; Maria D Odero; Giuseppe Zardo; Alicja Gruszka; Saverio Minucci; Pier Paolo Di Fiore; Pier Giuseppe Pelicci
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

6.  Molecular cytogenetic analyses of HIG, a novel human cell line carrying t(1;3)(p36.3;q25.3) established from a patient with chronic myelogenous leukemia in blastic crisis.

Authors:  Noriko Hosoya; Seishi Ogawa; Tohru Motokura; Akira Hangaishi; Lili Wang; Ying Qiao; Yasuhito Nannya; Mieko Kogi; Hisamaru Hirai
Journal:  Int J Hematol       Date:  2003-12       Impact factor: 2.490

7.  FISH analysis of hematological neoplasias with 1p36 rearrangements allows the definition of a cluster of 2.5 Mb included in the minimal region deleted in 1p36 deletion syndrome.

Authors:  Idoya Lahortiga; Iria Vázquez; Elena Belloni; José P Román; Patrizia Gasparini; Francisco J Novo; Isabel Zudaire; Pier G Pelicci; Jesús M Hernández; María J Calasanz; María D Odero
Journal:  Hum Genet       Date:  2005-03-03       Impact factor: 4.132

8.  Identification of potential biomarkers from microarray experiments using multiple criteria optimization.

Authors:  Matilde L Sánchez-Peña; Clara E Isaza; Jaileene Pérez-Morales; Cristina Rodríguez-Padilla; José M Castro; Mauricio Cabrera-Ríos
Journal:  Cancer Med       Date:  2013-02-27       Impact factor: 4.452

9.  An Optimization-Driven Analysis Pipeline to Uncover Biomarkers and Signaling Paths: Cervix Cancer.

Authors:  Enery Lorenzo; Katia Camacho-Caceres; Alexander J Ropelewski; Juan Rosas; Michael Ortiz-Mojer; Lynn Perez-Marty; Juan Irizarry; Valerie Gonzalez; Jesús A Rodríguez; Mauricio Cabrera-Rios; Clara Isaza
Journal:  Microarrays (Basel)       Date:  2015-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.